PDCD1 and neoplasm: In contrast, combining LSD1 inhibition with anti‐PD‐1 therapy effectively halted tumour growth and prevented relapse, likely through TME remodelling, enhanced CD8+ T cell activity and improved CD74‐mediated antigen presentation.